Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychomotor Agitation | 1 | 2022 | 31 | 0.750 |
Why?
|
| Dexmedetomidine | 1 | 2022 | 18 | 0.740 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 142 | 0.680 |
Why?
|
| Antipsychotic Agents | 1 | 2022 | 151 | 0.670 |
Why?
|
| Bipolar Disorder | 1 | 2022 | 405 | 0.620 |
Why?
|
| Substance Abuse Detection | 1 | 2018 | 12 | 0.580 |
Why?
|
| Medical History Taking | 1 | 2018 | 88 | 0.560 |
Why?
|
| Antidepressive Agents | 5 | 2022 | 113 | 0.460 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 451 | 0.410 |
Why?
|
| Depression | 7 | 2003 | 560 | 0.380 |
Why?
|
| Pain, Intractable | 2 | 1999 | 11 | 0.300 |
Why?
|
| Coma | 2 | 1999 | 52 | 0.290 |
Why?
|
| Ethics, Medical | 2 | 1999 | 312 | 0.250 |
Why?
|
| Depressive Disorder, Major | 1 | 2008 | 174 | 0.240 |
Why?
|
| Psychiatry | 2 | 2016 | 90 | 0.220 |
Why?
|
| Primary Health Care | 1 | 2008 | 391 | 0.210 |
Why?
|
| Tranylcypromine | 1 | 2022 | 2 | 0.190 |
Why?
|
| Administration, Sublingual | 1 | 2022 | 6 | 0.190 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2022 | 7 | 0.190 |
Why?
|
| Phenelzine | 1 | 2022 | 3 | 0.190 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2022 | 7 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 682 | 0.170 |
Why?
|
| Students, Medical | 2 | 2016 | 455 | 0.160 |
Why?
|
| Electronic Mail | 1 | 2016 | 17 | 0.120 |
Why?
|
| Narcolepsy | 1 | 1994 | 11 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 189 | 0.100 |
Why?
|
| Humans | 16 | 2022 | 96127 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 1994 | 300 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2016 | 854 | 0.080 |
Why?
|
| Family Practice | 2 | 2003 | 85 | 0.060 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 111 | 0.060 |
Why?
|
| Clinical Clerkship | 2 | 2016 | 125 | 0.050 |
Why?
|
| Decision Making | 2 | 1999 | 694 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2022 | 245 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 2860 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2003 | 983 | 0.040 |
Why?
|
| Female | 6 | 2016 | 50063 | 0.030 |
Why?
|
| Family | 1 | 1999 | 332 | 0.030 |
Why?
|
| Male | 4 | 2016 | 45870 | 0.030 |
Why?
|
| Michigan | 1 | 2016 | 57 | 0.030 |
Why?
|
| Iowa | 1 | 2015 | 35 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 189 | 0.030 |
Why?
|
| Universities | 1 | 2015 | 154 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2016 | 246 | 0.030 |
Why?
|
| Wakefulness | 1 | 1994 | 138 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 422 | 0.020 |
Why?
|
| Learning | 1 | 2016 | 305 | 0.020 |
Why?
|
| Reaction Time | 1 | 1994 | 323 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1994 | 910 | 0.020 |
Why?
|
| Emotions | 1 | 2015 | 377 | 0.020 |
Why?
|
| Adult | 3 | 2016 | 28718 | 0.020 |
Why?
|
| Aged | 1 | 2008 | 20964 | 0.020 |
Why?
|
| Sleep | 1 | 1994 | 458 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2883 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1994 | 824 | 0.020 |
Why?
|
| Middle Aged | 2 | 1999 | 28363 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 3147 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2003 | 25 | 0.010 |
Why?
|
| Self-Assessment | 1 | 2003 | 48 | 0.010 |
Why?
|
| Physicians, Family | 1 | 2003 | 40 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 7025 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2003 | 73 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2003 | 179 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 233 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 504 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 813 | 0.010 |
Why?
|
| Adolescent | 1 | 1994 | 9896 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 1011 | 0.010 |
Why?
|
| Mass Screening | 1 | 2003 | 710 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2003 | 635 | 0.010 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2003 | 647 | 0.010 |
Why?
|